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Introduction
Juvenile spondyloarthritis (J-spa) is characterized by a
predominantly peripheral involvement and more frequent
presentation as undifferentiated forms. However, like its
adult-onset equivalent, it has the potential to develop
structural damage and evolve to juvenile ankylosing spon-
dylitis (J-AS), with consequent functional impairment that
will last for the lifetime of the patient. Although descrip-
tions of jspa in worldwide different populations are scarce,
it has been suggested that clinical expression could be
different in Spanish and Mexican patients.
Objectives
Compare the patterns of musculoskeletal involvement in
J-spa patients from Spain and Mexico.
Methods
We conducted a descriptive study based on data of
mexespa study, which consists of binational cohort dis-
tributed in 10 Spanish centers and 6 Mexican. Analyzed
data were demographics, musculoskeletal manifestations,
metrology and diagnosis.
Results
A total of 128 patients were included, 95 from Spain
and 33 from Mexico. 65% of Spanish patients were boys
and 85% in Mexico. Mean age of onset was higher in Mexi-
can group (12 ± 3 years) than Spanish group (10 ± 4 years),
with a longer disease duration ofthe latter group. 94%
of Spanish patients were Caucasian, while in Mexico pre-
dominated white-Indian (64%). Frequency of HLA-B27 was
higher in Spain (47%) than Mexico (27%), as well as family
history of spa (45% and 18%, respectively). Almost all
patients in both countries had some type of musculos-
keletal symptom at the onset (95% in Spain and 94% in
Mexico). However, the patterns were different between
both countries. In Spain predominated peripheral arthritis
affecting lower extremities and peripheral enthesitis in
Mexico. In Spain 44% had peripheral entheses affected and
9% axial entheses, but these percentages were higher in
Mexico (36% and 85%, respectively). Mean modified
Schober was 6 cm in both groups and no other significant
differences were found in metrology. There were also no
significant differences in C-HAQ, BASDAI and BASFI
indexes, although these values were slightly higher in
Mexico. More patients in the Mexican cohort were
diagnosed with J-AS in Mexico (61%) than in the Spanish
(7%), but undifferentiated J-spa and psoriatic arthritis were
more frequent in the Spanish patients (46% and 36%,
respectively) than in Mexican patients (36% and 3%,
respectively).
Conclusion
Results show a different patterns of musculoskeletal
involvement in Spanish and Mexican J-spa. Differences
could be related to several aspects including social and
environmental factors, age of onset, genetics and different
J-spa subtypes, and the follow-up of those patients during1Rheumatology, University Hospital Ramon y Cajal, Madrid, Spain
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5 years will permit define better what factors are asso-
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